chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had every one of the typical Covid symptoms; had every one of the typical Covid symptoms; extreme fatigue/ fatigue and weakness; Muscle weakness/ leg weakness; sort of dizziness that made her feel off balance; sort of dizziness that made her feel off balance; Stomach ache; Chills; can't lift like she did before this; lost 3 pounds through this; Upset stomach; was miserable for almost 3 weeks; it triggered IBS symptoms as well; freezing; felt like she had a fever but she didn't have a thermometer to check her temperature; weakness/ still feeling weak; sore arm; Shortness of breath; This is a spontaneous report from a contactable consumer (patient's friend). This consumer reported similar events for himself and another patient. This report is 2nd of 2 reports.  A patient of an unspecified age and gender received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the reporter stated that she had a friend that had typical covid symptoms which she also had, and these symptoms only lasted at most 3 or 4 days. Typical covid symptoms experienced are extreme fatigue/ fatigue and weakness, muscle weakness/ leg weakness, sort of dizziness that made patient felt off balance, stomach ache, chills, shortness of breath, can't lift like the patient did before this, lost 3 pounds through this, upset stomach, was miserable for almost 3 weeks, it triggered IBS (irritable bowel syndrome) symptoms as well, freezing, felt like had a fever but didn't have a thermometer to check temperature, weakness/ still feeling weak, sore arm. Event typical covid symptoms was medically significant. The outcome of the events were recovered on an unknown date.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101507250 Same reporter/vaccine/event, different patients
Approx 10 min after receiving vaccine patient complained of lip tingling and numbness-on assessment, did appear to have some swelling/erythema to lower lip (was wearing mask on arrival so no baseline to compare); examined by clinic MD, was given first one dose of 25 mg Benadryl with no change/improvement, slight erythema noted in throat, second dose of 25mg Benadryl po given 10 min later--gradual / slow improvement. Held for observation for a full hour and 45min. VS remained stable/POX 99-100, lung/trach sounds remained cta. Released in improved state/stable--to f/u at facility if sx's return
pt recvd vax & mom states pt became fainty in the waiting room fell out of chair & jerked; nurse was called to waiting room-on arrival pt limp like & very pale glazed expression but no total loss of consciousness-no sz-like activity note;
After the initial injection within 2 weeks I began having heavy postnasal drip in the morning resulting in a build up of flem which had to be coughed up.  I also had a change in my digestive pattern.  When having bile movements the process was painful and laxative were needed for a short time.
Nausea for 24 hours Vomiting once Fever for 6 hours Headache for 24 hours Diarrhea for 24 hours
Within 6 weeks of 2nd dose, periods stopped, could not sleep more than 3 hours at a time, dry mouth at night and some during day. Complete life change.
20 days straight of menstrual bleeding. Weak and dizzy. Heart palpatations.
pt had grunting episodes, eyes rolling back, MD suggest these were signs of sz not to give DTP @ next dose; no tx;
Patient came in for the Moderna 0.25mL booster. Nurse drew-up and gave 0.02mL dose. Patient returned from waiting area and given the full 0.25mL dose.
Information has been received from a nurse referring to a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant therapy were not reported. On 21-AUG-2017, the patient was vaccinated with VARIVAX (lot # N002204, expiration date 19-JAN-2019) (route, dosage and frequency were not reported) which was improperly stored. The sterile diluent used to reconstitute the VARIVAX was properly stored. No symptoms reported. The vaccine was stored at -1.6 degree centigrade for 15 hours. The vaccine had previous temperature excursion which was stored at a temperature from -9 degree centigrade to 8 degree centigrade for 30 hours and 15 minutes. Data logger was involved. No further information was provided. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1708USA010758: US-009507513-1708USA010756: US-009507513-1708USA010757: US-009507513-1708USA010762: US-009507513-1708USA010759: US-009507513-1708USA010760: US-009507513-1708USA010754.
I still have pain; some limitations on muscle activity especially twisting; This is a spontaneous report from a contactable physician, the patient. A 57-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6206) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. The patient did not have any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not tested for COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11Mar2021, the patient experienced pain and some limitations on muscle activity especially twisting and with pain killers and hot shower, the pain decreased but returned one day later. Therapeutic measures were taken as a result of pain and some limitations on muscle activity especially twisting included treatment with painkillers and hot shower. The clinical outcome of the events pain and some limitations on muscle activity especially twisting was not recovered at the time of this report.   No follow up attempts are needed; No further information expected.
This spontaneous report was received from a physician and refers to a 33 year old patient patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 24-MAR-2016, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB (1 ml, intramuscularly in unspecified deltoid, lot # L042846, expiration date: 15-SEP-2017). No adverse events were reported. Administered dose of vaccine experienced the temperature excursion of 49 degree Fahrenheit. This is one of several reports received from the same reporter. Additional information is not expected as all the correspondence was returned by the post office.
ITP; platelet count 1000. Presented as petechiae and gingival bleeding on 12/26/01. Hospitalized on 12/26/01 until 12/27/01. Rx'd with Winrho.
Patient received vaccine at outside retail pharmacy.  Second dose lot # 045A21A.   Patient was admitted  5/13 from outpatient clinic with progression of bilateral distal extremity numbness/weakness that was initially noticed 5/10 and patient sought care from emergency services. Neurology was consulted and on 5/14 based on patient history, presentation, imaging and lumbar puncture diagnosed patient with Guillain-Barre with most likely cause being recent Moderna mRNA COVID vaccine (dates 03/08/21 and 04/05/21).  Per neurologist note Guillain Barré perhaps associated with Covid vaccination.  Overall fairly mild case with mostly numbness and tingling in the hands and feet with some ataxia due to poor sensation.  Treated with IVIG for 5 days and transferred to rehab facility.
Unusual crying for 5 hours, "twitching" for 5 days, temp 100.5 for 5 days.
102 fever (from about 9:00 pm to 9 am), then turned into mild fever.
CLIENT DEVELOPED 5CM OF ERYTHEMA AND INDURATION AROUND SITE OF INJECTION OF THE FLU VACCINE RIGHT DELTOID AREA, WARM TO PALPITATION.
Rash on back, abdomen, and back of legs started 2 days after getting GARDASIL, no rash or changes in skin at injection site. No treatment needed - this was 2nd dose of GARDASIL. Hydrocortisone prn if needed.
This spontaneous report has been received from a physician via a field representative referring to a female patient of unknown age with cold sores. Concomitant medication included anti-viral medication for cold sores. The patient's pertinent medical history and drug allergies were unknown. In approximately February 2017 (reported as about six months ago), the patient was vaccinated with ZOSTAVAX vial 19400 Plaque-Forming Unit (PFU), subcutaneous prevention of herpes zoster (dose, lot# and expiration date were not reported). In approximately February 2017, 1 day after injection, the patient had an allergic reaction and diffused rash all over the body. There was no treatment, no doctor visit and no hospitalization. No lab diagnostics were performed. The outcome of events was reported as recovered on an unknown date in 2017.
A non-serious spontaneous report of "administration of expired product" was received from a non healthcare professional concerning a 46-year-old female out of 18 patients. Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 15-Jan-2010. On 20-Jan-2010, the patient received expired H1N1, Intranasal. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved.
Pt recv vax on 11/11/98; post vax pt exp fever x 5 day; Tetramune not recommended in persons after 7 yr age
disequilibrium, dizziness, full ears which developed into tinnitus and ear aches, brain fog(difficult to concentrate) heart pain, vision tracking problems, paresthesia in arms ,shoulders, neck and head. Dizziness has been the most persistent symptom. other symptoms have begun to lessen after 12 weeks.
sick; muscle aches; fatigue; headache; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 10th May 2022, the patient received Shingles vaccine. In May 2022, less than a week after receiving Shingles vaccine, the patient experienced sickness, muscle pain, fatigue and headache. On an unknown date, the outcome of the sickness, muscle pain, fatigue and headache were not recovered/not resolved.   It was unknown if the reporter considered the sickness, muscle pain, fatigue and headache to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 13-MAY-2022 Reporter's Comments: The case was reported via interactive digital media. The patient received the shingles shot on Tuesday. On the reporting date, it was Friday and the patient was still sick with muscle aches, fatigue and a headache. The patient asked how much longer he/ she suffer with these effects.
21OCT slept all noc-not nl;22OCT 7AM projectile vomiting;2PM MD appt to ER high pitched cry, lethargic, 4PM adm to hosp;9AM projectile vomiting ICU;12PM eyes fixed to lt, staring, won't eat;22OCT-10NOV93 tx for hydroencephalitis,sz;
1st vaccine: I experienced extreme vertigo, vomitting, loss of awareness,  slurred speech and could not sit up.  Temperature dropped to 95.6°F despite several blankets, including a heated blanket and my husband laying inside of it with me to warm me up.   My body felt extremely cold, I was shivering, my skin turned ashen and my lips turned blue.   Dizziness and vomiting continued for the entire first day, and dizziness continued for over a week after the vaccine.  2nd vaccine:  Experienced high fever and headache for 2 days after vaccine, no other side effects.
Information received on 16MAY2018. The official reported that a patient received his 6-month dose of BIOTHRAX 2 months earlier than scheduled. No adverse events were noted. No further information is expected.
Nausea and severe pain in left shoulder/arm, where flu shot was administered.  Swelling/high heat/severe pain of arm - from shoulder to elbow began at same time, and has continued through this moment (it is currently: 12/17/2010 at 8:00 AM).  There may be a slight dissipation now of the pain (or I may simply be getting accustomed to the pain) -- but not of the swelling, redness or heat. There has been no/no shortness of breath.  But the swelling, heat and pain in the arm are still the same and my elbow is sagging now from the swelling.  Incidentally, I received the pneumonia vaccine at the same time in my right arm, and have had no reaction at all to that.
This spontaneous report as received from a registered nurse refers to a 15 months old patient. A patient received a dose of GARDASIL (lot # was reported as H020910, exp. date 18-JUN-2015) subcutaneously "in the arm" on 22-JAN-2013. No adverse effects has been observed or reported. Additional information has been requested.
Date of last missed period (LMP) was 3/11/2021, so the pregnancy was approx 5 weeks at the time of my second dose (positive pregnancy test on 4/9/21).  I got the injection of the second dose on 4/15/21 around 11 am and began bleeding and cramping due to miscarriage about 27 hours later. Miscarriage confirmed by OBGYN on monday 4/19/21.  I am blood type o-negative.  Will be tested for blood clotting disorder as possible cause of early pregnancy loss.  I should also state that I had a pretty severe case of "moderna arm" within just a few hours of the vaccination, maybe 4 hours, with approx 70% of my upper arm covered in deep red, hot, raised, swollen, and itchy skin that lasted several days.  I also got a fever of approx 101 degrees F about 20 hours after the vaccination.
Moderate and persistent nausea, body aches, chills, fatigue, lasting to present, 24 hours from onset, manageable with acetaminophen and ibuprofen. Very much like the flu.
Severe muscle aches, severe headache, nausea with vomiting, spent 24 hours unable to get out of bed. Symptoms completely resolved after 5 days.
Approximately 24 hours after vaccination, patient experienced nausea, vomiting, muscle aches, weakness, fatigue, severe chills, and loss of appetite. This lasted about one day.
covid arm; very very red, hot, itching and burning; red circle got really red and started burning and itching; big red bulls eye; swollen; hot area/hot; red; This spontaneous case was reported by a consumer and describes the occurrence of OCULAR HYPERAEMIA (big red bulls eye), VACCINATION SITE OEDEMA (swollen), VACCINATION SITE WARMTH (hot area/hot), VACCINATION SITE REACTION (covid arm) and VACCINATION SITE PRURITUS (very very red, hot, itching and burning) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE OEDEMA (swollen), VACCINATION SITE WARMTH (hot area/hot) and VACCINATION SITE ERYTHEMA (red). On 18-Mar-2021, the patient experienced OCULAR HYPERAEMIA (big red bulls eye), VACCINATION SITE PRURITUS (very very red, hot, itching and burning) and VACCINATION SITE PAIN (red circle got really red and started burning and itching). On an unknown date, the patient experienced VACCINATION SITE REACTION (covid arm). On 12-Mar-2021, VACCINATION SITE OEDEMA (swollen), VACCINATION SITE WARMTH (hot area/hot) and VACCINATION SITE ERYTHEMA (red) had resolved. On 19-Mar-2021, OCULAR HYPERAEMIA (big red bulls eye) had resolved. At the time of the report, VACCINATION SITE REACTION (covid arm), VACCINATION SITE PRURITUS (very very red, hot, itching and burning) and VACCINATION SITE PAIN (red circle got really red and started burning and itching) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were reported. Treatment information was unknown.   This case was linked to MOD-2021-267388 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Telephone contact report received on 28-JUL-2021. Added New events big red bulls eye and covid arm. Updated action taken from unknown to no change.
I2 hours later, woke up with really sore arm and some fatigue, headache. Everything kind of progressed as day went on . Sunday, didn't have headache but I had fatigue. Monday morning - woke up with liaisons on my tonsils, Tuesday and Wednesday and I had even more liaisons on my tonsils. Thursday: headache, muscle aches and I spiked a low grade fever and my throat was sore. I went to Urgent Care. They saw me and did a strep test and prescribed antibiotics which I started taking immediately and started feeling better on Friday and liaisons started going away on Saturday. Sunday I was feeling back to normal.
Site: Bruising at Injection Site-Severe, Site: Pain at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: PE and DVT  more prominent in/on the right side of body than left-Severe, Systemic: Vomiting-Medium, Systemic: Weakness-Severe, Additional Details: patient was diagnosed with COVID-19 in October 2020, but asymptomatic with underlying cough
No additional AE; HCP calling to report that a patient was administered a improperly stored vaccine.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 13-JUL-2023, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHa) (PROQUAD) injection, lot #W035460, expiration date: 06-MAY-2024, administered for prophylaxis (strength, and route of administration were not provided). This vaccine were improperly stored before administration (Product storage error). No additional adverse event was reported.
This spontaneous report as received from an other health professional refers to patients of unknown age. On an unknown date the patients were vaccinated with an improperly stored dose of VAQTA for prophylaxis which was stored from 9 Celsius degrees (°C) to 25°C. On an unknown date the patients experienced no adverse event. The outcome of incorrect product storage and no adverse event was unknown. The reporter considered incorrect product storage and no adverse event to be not related to VAQTA. Sender's Comments: US-009507513-1707USA011201: US-009507513-1707USA011790: US-009507513-1707USA011791: US-009507513-1707USA011792.
Information has been received from a registered nurse regarding a patient of an unknown age and gender. On 23-OCt-2013 at 17:30, ZOSTAVAX lot # J004268 was exposed to -14C for an estimated total time out of range of 10.0 hours. On 25-OCt-2013 at 18:30, ZOSTAVAX lot # J004268 was exposed to an exact T not recorded but noted as equal to or >12C for an estimated total time out of range of 10.5 hours. On 04-NOV-2013, the patient was vaccinated with an out of range dose of ZOSTAVAX (dose and route administration were not provided) (Lot number J004268, Exp. Date: 12-JUL-2014). No adverse experience had been reported. This is one of 182 reports from the same source. Additional information has been requested.
Pt experienced joint pain (albows and knees) following the vaccination. Symptoms came on about 5 hours later and lasted for roughly 24 hours.
This spontaneous report was received from a registered nurse regarding a 6 years old patient unknown gender. The patients' medical history, drug reactions/allergies and concomitant medications were not provided. On unknown dates, the patient was vaccinated with improperly stored doses of M-M-R II  lot # N024696, expiration date 07-APR-2019 for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent (manufacturer unknown). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 9 to 25 (8.6) degrees Celsius for 16 minutes. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1805USA000142:
3/28/07 Fever increased to 101, malaise, hurting in back of neck and back, right sided weakness. Saw Doctor. Placed on Cortisone injection, Prednisone PO, Cefuroxime 500mg PO.
vertigo; dizziness; anxiety; panic attacks; This is a spontaneous report from a contactable consumer (reporter's father) . A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number and Expiry date was not reported), via an unspecified route of administration on unspecified date as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications was not reported. On an unspecified date, his main concern right now is his dizziness, vertigo, anxiety, panic attacks and he also mentioned that his Dad who got also the Pfizer-BioNTech Covid19 Vaccine is beginning to have the similar problem. The outcome for the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  Lot/batch number is not available. Follow-up attempts have been completed and no further information is expected